Dolby Labs owners report 8.2% and 6.4% stakes
Dolby Laboratories, Inc. Schedule 13G/A Amendment No. 5 reports beneficial ownership stakes held by Morgan Stanley reporting units and Atlanta Capital Management Company, LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dolby Laboratories, Inc. Schedule 13G/A Amendment No. 5 reports beneficial ownership stakes held by Morgan Stanley reporting units and Atlanta Capital Management Company, LLC. The filing lists 5,020,777 shares (8.2%) attributed to Morgan Stanley reporting units and 3,925,085 shares (6.4%) attributed to Atlanta Capital Management. The cover shows Class A Common Stock (CUSIP 25659T107) and includes signed joint filing and Item 7 exhibits. Signatures are dated 05/11/2026.
Insights
Filing documents institutional beneficial ownership percentages and joint reporting.
The Schedule 13G/A amendment identifies Morgan Stanley reporting units with 4,230,948 shared voting power and 4,819,090 shared dispositive power, and lists 5,020,777 shares beneficially owned (8.2%).
The filing is joint with Atlanta Capital Management Company, LLC, which reports 3,516,715 shared voting power, 3,734,611 shared dispositive power, and 3,925,085 shares (6.4%). The document includes a Joint Filing Agreement and Item 7 exhibit describing MS Reporting Units.
Two institutional holders report sizable passive stakes in Dolby Class A shares.
The amendment frames the positions as joint reporting by specific units: Morgan Stanley's MS Reporting Units are disclosed separately per the referenced Release, and Atlanta Capital's filings are similarly enumerated. The filing uses shared voting/dispositive columns to show control attributes.
Cash‑flow treatment or plans to transact are not stated; subsequent schedule filings would show any changes in direction or magnitude.
Key Figures
Key Terms
beneficially owned regulatory
MS Reporting Units regulatory
Joint Filing Agreement legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Dolby Laboratories' Schedule 13G/A Amendment No. 5 report?
Who are the reporting persons named in the 13G/A for DLB?
What voting and dispositive powers are disclosed for Morgan Stanley?
Does the filing indicate these are joint filings or aggregated holdings?
Are transaction intentions or trading plans disclosed in this amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.